Trials, 22 Trials, Vol 22, Iss 1, Pp 1-9 (2021) Wientjes, M H M, Atiqi, S, Wolbink, G J, Nurmohamed, M T, Boers, M, Rispens, T, de Vries, A, van Vollenhoven, R F, van den Bemt, B J F & den Broeder, A A 2021, ' Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch) : study protocol for a fully blinded randomised superiority test-treatment trial ', Trials, vol. 22, no. 1, 406, pp. 406 . https://doi.org/10.1186/s13063-021-05358-7 Trials, 22(1):406. BioMed Central Trials, 22, 1 Trials
European journal of immunology, 50(8), 1113-1125. Wiley-VCH Verlag European Journal of Immunology, 50(8), 1113-1125. Wiley-VCH Verlag Unger, P P A, Lighaam, L C, Vermeulen, E, Kruithof, S, Makuch, M, Culver, E L, van Bruggen, R, Remmerswaal, E B M, ten Berge, I J M, Emmens, R W, Niessen, H W M, Barnes, E, Wolbink, G J, van Ham, S M & Rispens, T 2020, ' Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses ', European Journal of Immunology, vol. 50, no. 8, pp. 1113-1125 . https://doi.org/10.1002/eji.201948454